Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Molecules ; 25(4)2020 Feb 20.
Article in English | MEDLINE | ID: mdl-32093423

ABSTRACT

Bersavine is the new bisbenzylisoquinoline alkaloid isolated from the Berberis vulgaris L.(Berberidaceae) plant. The results of cytotoxicity screening 48 h post-treatment showed thatbersavine considerably inhibits the proliferation and viability of leukemic (Jurkat, MOLT-4), colon(HT-29), cervix (HeLa) and breast (MCF-7) cancer cells with IC50 values ranging from 8.1 to 11 µM.The viability and proliferation of leukemic Jurkat and MOLT-4 cells were decreased after bersavinetreatment in a time- and dose-dependent manner. Bersavine manifested concentration-dependentantiproliferative activity in human lung, breast, ovarian and hepatocellular carcinoma cell linesusing a xCELLigence assay. Significantly higher percentages of MOLT-4 cells exposed to bersavineat 20 µM for 24 h were arrested in the G1 phase of the cell cycle using the flow cytometry method.The higher percentage of apoptotic cells was measured after 24 h of bersavine treatment. Theupregulation of p53 phosphorylated on Ser392 was detected during the progression of MOLT-4 cellapoptosis. Mechanistically, bersavine-induced apoptosis is an effect of increased activity ofcaspases, while reduced proliferation seems dependent on increased Chk1 Ser345 phosphorylationand decreased Rb Ser807/811 phosphorylation in human leukemic cells.


Subject(s)
Alkaloids , Antineoplastic Agents, Phytogenic , Apoptosis/drug effects , Berberis/chemistry , Cytotoxins , G1 Phase/drug effects , Leukemia/drug therapy , Alkaloids/chemistry , Alkaloids/isolation & purification , Alkaloids/pharmacology , Antineoplastic Agents, Phytogenic/chemistry , Antineoplastic Agents, Phytogenic/isolation & purification , Antineoplastic Agents, Phytogenic/pharmacology , Cytotoxins/chemistry , Cytotoxins/isolation & purification , Cytotoxins/pharmacology , Drug Screening Assays, Antitumor , HT29 Cells , HeLa Cells , Hep G2 Cells , Humans , Jurkat Cells , Leukemia/metabolism , Leukemia/pathology , MCF-7 Cells
2.
Sci Rep ; 8(1): 4829, 2018 03 19.
Article in English | MEDLINE | ID: mdl-29555944

ABSTRACT

Scoulerine is an isoquinoline alkaloid, which indicated promising suppression of cancer cells growth. However, the mode of action (MOA) remained unclear. Cytotoxic and antiproliferative properties were determined in this study. Scoulerine reduces the mitochondrial dehydrogenases activity of the evaluated leukemic cells with IC50 values ranging from 2.7 to 6.5 µM. The xCELLigence system revealed that scoulerine exerted potent antiproliferative activity in lung, ovarian and breast carcinoma cell lines. Jurkat and MOLT-4 leukemic cells treated with scoulerine were decreased in proliferation and viability. Scoulerine acted to inhibit proliferation through inducing G2 or M-phase cell cycle arrest, which correlates well with the observed breakdown of the microtubule network, increased Chk1 Ser345, Chk2 Thr68 and mitotic H3 Ser10 phosphorylation. Scoulerine was able to activate apoptosis, as determined by p53 upregulation, increase caspase activity, Annexin V and TUNEL labeling. Results highlight the potent antiproliferative and proapoptotic function of scoulerine in cancer cells caused by its ability to interfere with the microtubule elements of the cytoskeleton, checkpoint kinase signaling and p53 proteins. This is the first study of the mechanism of scoulerine at cellular and molecular level. Scoulerine is a potent antimitotic compound and that it merits further investigation as an anticancer drug.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Berberine Alkaloids/pharmacology , Cell Cycle Checkpoints/drug effects , Microtubules/drug effects , Microtubules/metabolism , Antineoplastic Agents/chemistry , Berberine Alkaloids/chemistry , Carboxylic Acids/chemistry , Caspases/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , DNA Breaks/drug effects , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Esters/chemistry , Humans , Membrane Potential, Mitochondrial/drug effects , Phosphorylation/drug effects , Signal Transduction/drug effects
3.
Nat Prod Commun ; 11(6): 753-6, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27534109

ABSTRACT

Forty-six isoquinoline alkaloids, of eleven structural types isolated in our laboratory, have been evaluated for their cytotoxicity against two cancer cell lines (Caco-2 and Hep-G2 cancer cells), as well as against normal human lung fibroblast cells. Only scoulerine, aromoline, berbamine and parfumidine showed significant cytotoxic effects, but only scoulerine was active against both Caco-2 and Hep-G2 cells (IC50 values 6.44 ± 0.87 and 4.57 ± 0.42, respectively). Unfortunately, except for parfumidine, the other active alkaloids were also cytotoxic to the normal human lung fibroblast cells.


Subject(s)
Alkaloids/chemistry , Alkaloids/toxicity , Isoquinolines/chemistry , Isoquinolines/toxicity , Caco-2 Cells , Cell Survival/drug effects , Hep G2 Cells , Humans
4.
Nat Prod Commun ; 11(10): 1587-1594, 2016 Oct.
Article in English | MEDLINE | ID: mdl-30549626

ABSTRACT

Modem research has shown that Amaryllidaceae alkaloids represent a rich reservoir of potential small chemical molecules exhibiting several medicinal properties through various mechanisms. Among the many Amaryllidaceae compounds, galanthamine has been given a great amount of attention due to the fact that it possesses potent acetylcholinesterase inhibitory activity. In spite of the amount of evidence indicating the potential usefulness of Amaryllidaceae alkaloids in therapy, research groups have focused their attention on the other alkaloids present in this plant family. New investigations have shed light on - many aspects of the structure of Amaryllidaceae alkaloids and on their semisynthetic modification, function, and mechanisms underlying in vitro and in vivo activity. In addition, Amaryllidaceae alkaloids have frequently been identified as having promising cytotoxic properties against cancer cell lines. While follow- up studies have repeatedly shown that Amaryllidaceae alkaloids and their derivatives demonstrate antiproliferative, cytotoxic and apoptosis-inducing activity, the mechanisms remain unclear. This review addresses the most important Amaryllidaceae alkaloids with anticancer potential, particularly those that have been studied for the purpose of gaining a better understanding of the basis of the activity at the cellular and molecular level.


Subject(s)
Alkaloids/pharmacology , Amaryllidaceae/chemistry , Antineoplastic Agents, Phytogenic/pharmacology , Cholinesterase Inhibitors/pharmacology , Alkaloids/therapeutic use , Animals , Antineoplastic Agents, Phytogenic/therapeutic use , Cholinesterase Inhibitors/therapeutic use , Humans
SELECTION OF CITATIONS
SEARCH DETAIL